Figure 1.
Results of AAS-7 scores. No angioedema attack was detected during COVID-19 in 5 of the 10 patients. Two patients experienced a significant increase in angioedema activity during COVID-19 compared with basal activity scores. Three patients had a similar or lower attack frequency than their previous level. Four patients had a relative increase in their attacks during the post–COVID-19 period. AAS-7 = 7-day Angioedema Activity Score; COVID-19 = coronavirus disease 2019.
